A virtual form exploration, not a prediction of treatment results.
01 / MATERIAL
What is within.
Look into the material.
An HA gel composed of cross-linked hyaluronic acid and lidocaine hydrochloride. Discover the material through its light-catching texture.
HYALURONIC ACID / TEXTURE 01
↔ Drag to explore three gel textures
CROSS-LINKED HA24mg/mL
Cross-linked hyaluronic acid
LIDOCAINE HCl0.3%
Lidocaine hydrochloride
SYRINGE VOLUME1.1mL
Syringe volume
Supplied gel texture photographs; not test-result images.
02 / STRUCTURE & PERFORMANCE
From structure to performance.
Explore processes and reported test values from the manufacturer’s technical materials.
HBCT / MICROSTRUCTURE
Structure by design.
Microstructure, beginning with low-temperature crosslinking.
The manufacturer describes the three-dimensional HA gel microstructure through its HBCT low-temperature crosslinking process.
SAMPLE AHBCT HA
Original SEM images. Magnification, preparation and replicate details were not supplied. Images alone do not quantify clinical superiority.
RHEOLOGY / G′
Storage modulus G′
Ranges by manufacturer formulation
Fine60–120Pa
0150300 Pa
Drag or select a formulation
Bars show reported ranges, not means or error bars. Temperature, frequency, strain and replicate details were not supplied.
MGT / EXTRUSION
Consistency in motion.
13.62N
Manufacturer’s Deep formulation · 27G needle · average extrusion force
MGT is a micro-grinding process for consistent gel processing. The displayed value is the mean reported in the manufacturer’s test.
COHESIVENESS
Held together.
Cohesiveness test · lengths shown in the source
Fine2.4cm
Deep2.1cm
Volume2.0cm
Test speed, temperature and replicate details were not supplied. Lengths are not a ranking of clinical performance.
03 / PURITY
Purity, measured.
Explore raw-material criteria separately from final-product test results.
RAW MATERIAL
HA raw-material criteria
Endotoxin
≤ 0.020 IU/mg
Microbial contamination
≤ 5 CFU/g
FINAL PRODUCT
Final-product test table
Residual BDDE
0 ppm / reported
Heavy metals
< 1.0 ppm / reported
PURIFICATION02
Two stages · two weeks
Manufacturer’s technical data. 0 ppm is a reported result, not proof of absolute absence; the detection limit was not supplied.
04 / PRECLINICAL OBSERVATION
Observed over time.
Original animal-study MRI of a low-elasticity formulation. Select an observation interval.
MRI / OBSERVATION SERIES
0 weeks1 weeks2 weeks3 weeks
4 weeks8 weeks16 weeks24 weeks
KBIOHealth Animal Center · 2020.09.18–2021.03.23. These are observation times, not evidence of human longevity, retention or safety.
05 / THE COLLECTION
The collection, at a glance.
Product specifications
Ep. Alpha
Ep. Beta
Ep. Gamma
Cross-linked hyaluronic acid
24 mg/mL
24 mg/mL
24 mg/mL
Lidocaine hydrochloride
3 mg/mL (0.3%)
3 mg/mL (0.3%)
3 mg/mL (0.3%)
Syringe volume
1.1 mL
1.1 mL
1.1 mL
Needle
30G × 2
27G × 1
25G × 1
Cannula
—
25G × 1
23G × 1
Based on Aestyve carton labels. Store at 2–25°C, away from light and moisture. Refer to the latest label and instructions for expiry, lot and use information.
Materials and sources
Composition, volume and accessories: Aestyve packaging (P01). Process and test data: manufacturer technical materials dated 2026.01.26, pp.4–6, 9 (T01), and English manufacturer brochure p.1 (T02). Content follows the 2026 HA Collection catalog worksheet. Fine, Deep and Volume are manufacturer formulation names; these are not presented as Aestyve clinical outcomes.
Manufacturing-document scope is reviewed against the supplied product’s label, lot and expiry. Manufacturing information is provided on a product-specific basis.
Documentation
Product documentation
Request specifications, labeling / IFU, applicable finished-product CoA and registration documents. Document availability is confirmed for the product and destination market.
Available Markets
Market availability
Tell us your destination country and importing entity. Availability is confirmed after review of product-specific registration and import requirements.
Displayed specifications follow brand-provided information. Verify the current supply label and specifications when ordering.
We review raw-material and finished-product documentation according to the product’s characteristics and applicable specifications.
Composition & properties
Material identity, composition, concentration, pH and product-specific physical specifications
Finished-product testing
Applicable sterility or microbial, endotoxin and residual-substance test parameters
Lot traceability & packaging
Lot number, expiry, fill volume, package integrity and storage conditions
For HA products, we also review applicable residual BDDE specifications for cross-linked formulations, viscoelasticity and osmolality.
We publish certifications and test values only when valid supporting documents have been verified for the relevant product, model, manufacturing site or lot. We check the issuer, issue date and scope, and distinguish raw-material results from finished-product results.
These are product-specific review criteria, not a statement that every product has completed every test or holds a certification.
